Arkus Innovation Studios

Von Braun Labs + Stanford — Diagnostic

72 hours. 8 ventures. 3 Accelerate, 3 Incubate, 1 Develop, 1 Watch. Validated live by the portfolio's Stanford domain expert.

Eight semiconductor ventures, one decision window, and traditional evaluation methods that could not match speed requirements. Von Braun Labs needed to allocate capital, engineering time, and partnership bandwidth across a time-sensitive portfolio.

The portfolio sat inside an ICT context with foundry access, EDA tooling, and contract manufacturing across four continents. A Stanford professor with 20+ years of domain expertise joined live review, requiring outputs that could stand up in real-time technical scrutiny.

Forensic IP assessment: Seven review passes (technology, patent, market, regulatory, commercial, financial, synthesis), nine-component report per venture, and patent verification across USPTO and EPO.

Venture readiness validation: Executive summary and full validation report per venture, including market dynamics, regulatory pathway, financial roadmap, and surfaced risk.

Prioritization matrix: Multi-criteria scoring with sector-adjusted weighting, mapping global potential against domestic strength and commercial readiness.

Reliability pass: Each report run three times, matrix configured four ways, findings checked for consistency across runs.

The portfolio sorted into four clean action buckets with direct resource implications for commercialization, incubation support, and monitoring cadence.

Arkus assessed technical merit and IP; it did not assess business quality, founder fit, or commercial viability. Those judgments stayed with Von Braun Labs and the portfolio domain expert.

This boundary is deliberate. Sophisticated funds avoid outsourcing final business judgment to preserve investment accountability and reduce assessment bias.